ArticleFrontiers of medicine2022

Renin-angiotensin system inhibitor is associated with the reduced risk of all-cause mortality in COVID-19 among patients with/without hypertension.

Huai-Yu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.